National Institute of Allergy and Infectious Diseases (NIAID): all 2,445 studies
Page 9 of 25. Open to participants first (182), then studies with results posted, then the rest; newest registration first within each.
- A Cluster-randomized Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes Aegypti Mosquitoes in Reducing the Incidence of Arboviral Infection in Brazil (EVITA Dengue)CompletedNCT04514107Not applicable
- ACTIV-3: Therapeutics for Inpatients With COVID-19CompletedNCT04501978Phase 3
- A Longitudinal Study of COVID-19 Sequelae and ImmunityActive, not recruitingNCT04411147
- Sample Collection for Systems Evaluation of Patients With Unknown or Incompletely Characterized Immune DefectsCompletedNCT04408950
- COVID-19 Associated Lymphopenia Pathogenesis Study in BloodCompletedNCT04401436
- Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND)WithdrawnNCT04394884
- Surveillance of Individuals Following SARS-CoV-2 InfectionCompletedNCT04383444
- Immunophenotyping Assessment in a COVID-19 CohortCompletedNCT04378777
- Matched Related and Unrelated Donor Stem Cell Transplantation for Severe Combined Immune Deficiency (SCID): Busulfan-based Conditioning With h-ATG, Radiation, and SirolimusWithdrawnNCT04370795Phase 1/2
- Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal InfectionCompletedNCT04350138Phase 2
- Collection of Anti-SARS-CoV-2 Immune PlasmaCompletedNCT04344977
- Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment InterruptionActive, not recruitingNCT04340596Phase 1
- SARS-COV2 Pandemic Serosurvey and Blood SamplingCompletedNCT04334954
- Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIVWithdrawnNCT04334915Phase 2
- Evaluation and Follow-up of People With Tick-borne DiseasesWithdrawnNCT04318925
- Malaria Prevalence Around Maferinyah, GuineaCompletedNCT04105855
- Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral TherapyWithdrawnNCT04046107Phase 1/2
- Evaluating the Safety and Immunogenicity of a Prime-boost Vaccine Regimen of GEO-D02 DNA and MVA/HIV62B With and Without B63521^11 gp120 and IHV01 gp120 Env Proteins in Healthy, HIV-uninfected Adult ParticipantsWithdrawnNCT04041674Phase 1
- Glutamine Supplementation in People With Immune DysregulationWithdrawnNCT04019769Early Phase 1
- Elemental Diet for Treatment of Inflammatory Bowel Disease in Patients With Chronic Granulomatous DiseaseCompletedNCT03983837Phase 2
- Skin Immunity Sample Collection Involving Blisters and BiopsiesWithdrawnNCT03921515Early Phase 1
- Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant CyclophosphamideActive, not recruitingNCT03910452Early Phase 1
- An Observational Study to Assess the Prevalence and Outcomes of Primary Pulmonary Coccidioidomycosis in Persons Aged > / = 14 Years Presenting With Community Acquired Pneumonia (CAP) in Endemic Areas (SAnds-PPC)CompletedNCT03908632
- Mucosal and Systemic Immunity After Viral Challenge of Healthy Volunteers Vaccinated With Inactivated Influenza Vaccine Via the Intranasal Versus Intramuscular RouteCompletedNCT03845231Phase 2
- Retrospective Chart Review of Candida FungemiaCompletedNCT03827330
- Prevalence and Incidence of Lassa Virus Infection in Southern MaliCompletedNCT03783143
- PREVAIL VIII: A CoHOrt Clinical, Viral, and ImmuNOlogic Monitoring Study of People Living With Retroviral Infection in Liberia (HONOR)CompletedNCT03733093
- Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) HaploinsufficiencyWithdrawnNCT03733067Phase 1/2
- Plasmodium and Other Parasites in Pregnant Women and Children Around Margibi and Montserrado Counties, LiberiaCompletedNCT03719599
- Inpatient Challenge Study of rRSV A/Maryland/001/11, a Human Respiratory Syncytial Virus Challenge Strain, Administered to Healthy Adult VolunteersCompletedNCT03624790Phase 1
- A Study to Evaluate the Safety and Pharmacokinetics of NTM-1633 vs Placebo Administered Intravenously in Healthy AdultsCompletedNCT03603665Phase 1
- rCSP/AP10-602 [GLA-LSQ] Vaccine TrialCompletedNCT03589794Phase 1
- A Study in Healthy Adults to Assess Priming With Antigenically Mismatched Live Attenuated A/H7N3 Influenza Virus Vaccine Followed by Inactivated A/H7N9 Influenza Virus VaccineCompletedNCT03581903Phase 1
- Liver Transplantation With Tregs at MGHCompletedNCT03577431Phase 1/2
- Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis PatientsActive, not recruitingNCT03568383Phase 3
- Vaginal Microbiome Exposure and Immune Responses in C-section InfantsActive, not recruitingNCT03567707Early Phase 1
- Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in ChildrenCompletedNCT03534245
- Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell LymphocytopeniaActive, not recruitingNCT03519464Phase 2
- Evaluating the Safety and Immunogenicity of the IHV01 Protein Vaccine Primed and Co-Administered With HIV DNA CON-S Env Vaccine in Healthy, HIV-1-Uninfected AdultsWithdrawnNCT03505060Phase 1
- Tolerance by Engaging Antigen During Cellular HomeostasisCompletedNCT03504241Phase 1
- Safety and Pharmacokinetics Study of DM1157 to Treat MalariaTerminatedNCT03490162Phase 1
- A Safety and Immunogenicity Study of Intranasal Sendai Virus Vectored Respiratory Syncytial Virus (SeVRSV) Vaccine in Healthy AdultsCompletedNCT03473002Phase 1
- H5N1 With or Without Topical Aldara in Healthy AdultsCompletedNCT03472976Phase 1
- Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope GlycoproteinTerminatedNCT03462004Phase 1
- Evaluation of the Efficacy of the Live Attenuated Tetravalent Dengue Vaccine Against DENV-2 and DENV-3 ChallengeCompletedNCT03416036Phase 1
- Pharmacokinetic Study of Dapivirine Gel Administered Rectally to HIV-1 Seronegative AdultsCompletedNCT03393468Phase 1
- Ustekinumab (Anti-IL-12/23p40 Monoclonal Antibody) in Patients With Leukocyte Adhesion Deficiency Type 1 (LAD1) Who Have Inflammatory PathologyCompletedNCT03366142Phase 1/2
- Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined ImmunodeficiencyStatus unknownNCT03315078Phase 1/2
- Community Dynamics of Malaria Transmission and Mosquito Feeding in Bancoumana, MaliCompletedNCT03304704
- Molecular Basis of Erythrocyte Invasion by Plasmodium Vivax Into Duffy-Negative Erythrocytes in MaliCompletedNCT03304691
- A Safety, Tolerability, Pharmacokinetics and Immunogenicity Trial of Co-administered MERS-CoV Antibodies REGN3048 and REGN3051CompletedNCT03301090Phase 1
- PREDICT Cytomegalovirus (CMV)CompletedNCT03300882
- Natural History of Intestinal Inflammation in People With Primary Immune DysregulationsWithdrawnNCT03278912
- Impact of a Short-Term Analytical Treatment Interruption and Re-Initiation of Antiretroviral Therapy on Immunologic and Virologic Parameters in HIV-Infected IndividualsCompletedNCT03225118
- Trial to Evaluate the Safety, Immunogenicity and Protective Efficacy of Three or Five Administrations of GAP3KO SporozoitesCompletedNCT03168854Phase 1
- Atopic Dermatitis (AD) and Food AllergyCompletedNCT03168113
- A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel)(R) With or Without AP 10-701 for Intestinal Schistosomiasis in Healthy Exposed AdultsCompletedNCT03110757Phase 1
- PREVAIL VI: Identification of Host Genetic Factors Underlying Ebola Virus Disease Risk, Mortality, Long-term Sequelae, Viral RNA Persistence, Humoral Immunity, and Ebola Vaccine ResponseCompletedNCT03098862
- Herpesviruses Reactivation In Hiv-Infected Women Initiating ART (HERA)CompletedNCT03092505
- CD8 Reactivity to Microorganisms in Blood and Breast MilkTerminatedNCT03084614
- Etiology of Eczema Herpeticum (EH)CompletedNCT03038932
- Phase I Trial of Measles Vectored Chikungungya VaccineCompletedNCT03028441Phase 1
- Beginning Assessment of Cutaneous Treatment Efficacy of Roseomonas in Atopic DermatitisCompletedNCT03018275Phase 1/2
- H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: ImmunologyCompletedNCT03014310Phase 1
- A Systems Biology Approach to Malaria ImmunityCompletedNCT03014258Phase 1
- Safety and Immune Response to a Clade C DNA HIV VaccineCompletedNCT02997969Phase 1
- Safety and Efficacy of Sanaria's PfSPZ-CVac in Malian AdultsCompletedNCT02996695Phase 1
- VRC 320: A Phase I, Randomized Clinical Trial to Evaluate the Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA090-00-VP, Administered Via Needle and Syringe or Needle-free Injector, PharmaJet, inHealthy AdultsCompletedNCT02996461Phase 1
- Impact of Malaria on Pregnant Women in Ouelessebougou, MaliCompletedNCT02974608
- A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects.CompletedNCT02963909Phase 1
- Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 AdjuvantCompletedNCT02957656Phase 1
- ZIKA Vaccine in Naive SubjectsCompletedNCT02952833Phase 1
- Evaluating the Infectivity, Safety, and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants and Children 6 to 24 Months of AgeCompletedNCT02952339Phase 1
- Safety and Effectiveness of a Seasonal Live Attenuated Influenza Vaccine in a Human Challenge Model of Infection With Wild-type (wt) Influenza A/California/2009 (H1N1)-Like VirusWithdrawnNCT02950688Phase 1
- Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants and Children 6 to 24 Months of AgeTerminatedNCT02948127Phase 1
- Novel Mobile Device Application to Improve AdherenceCompletedNCT02904278Not applicable
- Post-Traumatic Stress Symptoms (PTSS) in Transplant RecipientsCompletedNCT02892266
- A Safety Trial to Test MVA-BN(R)-Filo and Ad26.ZEBOV Vaccines in Healthy VolunteersCompletedNCT02891980Phase 1
- Evaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v DiseaseTerminatedNCT02883426Phase 1
- Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of AgeCompletedNCT02879266Phase 1
- Evaluating the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With rDEN3Δ30CompletedNCT02873260Phase 1
- Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA085-00-VP, in Healthy AdultsCompletedNCT02840487Phase 1
- PfSPZ Challenge in Non-immune Adults in Baltimore, USACompletedNCT02780154Phase 1
- Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632CompletedNCT02779140Phase 1
- PfSPZ Challenge in Healthy Malaria-Naïve Adults in the United StatesCompletedNCT02773979Phase 1
- Impact of Allo- and Autoantibodies on Chronic Cardiac Allograft FunctionCompletedNCT02752789
- A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy VolunteersCompletedNCT02743455Phase 1
- Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With SchistosomiasisWithdrawnNCT02734186Phase 4
- Cefixime / Azithromycin pK StudyCompletedNCT02708992Phase 1
- Microbial, Immune, and Metabolic Perturbations by Antibiotics (MIME Study)CompletedNCT02707042Phase 1
- Screening for Alpha Thalassemia in Healthy VolunteersActive, not recruitingNCT02692872
- 11C-5-HTP PET in Clinical Islet TransplantationCompletedNCT02689479Not applicable
- Evaluation of the Safety and Immunogenicity of rDEN3Δ30, a Live Attenuated Monovalent Dengue Virus VaccineCompletedNCT02684383Phase 1
- Safety and Immunogenicity of Sanaria's Irradiated Sporozoite Vaccine (PfSPZ Vaccine) in Malaria-Experienced Adults in Burkina FasoCompletedNCT02663700Phase 1
- Impact of Antimalarial Treatment on Measures of T Cell Suppression/Regulation in Healthy Adults From Doneguebougou, MaliCompletedNCT02659566
- Evaluating the Safety, Tolerability, and Immunogenicity of a Prime-Boost Regimen of HIV-1 Nef/Tat/Vif, Env pDNA Vaccine Delivered Intramuscularly With Electroporation and HIV-1 rVSV envC Vaccine in Healthy, HIV-Uninfected AdultsCompletedNCT02654080Phase 1
- CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)CompletedNCT02652546Phase 1
- Artemether-lumefantrine Resistance Monitoring in Children With Uncomplicated Plasmodium Falciparum Malaria in MaliCompletedNCT02645604
- CLAD Phenotype Specific Risk Factors and MechanismsCompletedNCT02631720
- Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima PeruCompletedNCT02630082Not applicable
← National Institute of Allergy and Infectious Diseases (NIAID) overview and focus areas